Skip to main content
OpenTrials

Clinical trial condition

Digestive System Diseases

Explore clinical trials studying Digestive System Diseases. Study availability and eligibility vary by location and protocol.

305 public trials 54 recruiting studies
Refine in advanced search Browse all conditions

Digestive System Diseases trial results

Completed

Study Evaluating the Safety, Efficacy and Tolerability of BIO89-100 in Subjects With Biopsy-confirmed Nonalcoholic Steatohepatitis (NASH)

NCT04929483

Conditions
Digestive System Diseases, Fatty Liver, Liver Diseases, +4 more
Locations
  • 89bio Clinical Study Site Birmingham, Alabama, United States
  • 89bio Clinical Study Site Birmingham, Alabama, United States
  • 89bio Clinical Study Site Dothan, Alabama, United States
  • 89bio Clinical Study Site Guntersville, Alabama, United States
View all 89 locations
View Trial Details
Completed

Polygen Defi-Alpha: Genetic Polymorphisms Study in Children With Alpha-1 Antitrypsin Deficiency, Included in the DEFI-ALPHA Cohort

NCT01862211

Conditions
Children With a Deficiency of Alpha-1 Antitrypsin, Digestive System Diseases
Locations
  • CHU d'Amiens - Hopital Nord Amiens, France
  • CHU de BESANCON Besançon, France
  • Hôpital Pellegrin Bordeaux, France
  • Hôpital Femme Mère Enfant de Lyon Bron, France
View all 20 locations
View Trial Details
Completed

A Study to Evaluate the Efficacy and Safety of CIN-102 (Deudomperidone) in Adults With Diabetic Gastroparesis

NCT05832151

Conditions
Diabetic Gastroparesis, Digestive System Diseases, Gastrointestinal Diseases, +9 more
Locations
  • Digestive Health Specialists of the Southeast Dothan, Alabama, United States
  • G & L Research, LLC Foley, Alabama, United States
  • Clinical Research Associates, LLC Huntsville, Alabama, United States
  • Phoenix Medical Research Institute, LLC Peoria, Arizona, United States
View all 100 locations
View Trial Details
Completed

A Study to Evaluate Safety, Tolerability and Pharmacokinetics of Two Different Doses of Alpha1-Proteinase Inhibitor Subcutaneous (Human) 15% in Participants With Alpha1-Antitrypsin Deficiency

NCT04722887

Conditions
Alpha1-Antitrypsin Deficiency, Chronic Disease, Congenital, Hereditary, and Neonatal Diseases and Abnormalities, +14 more
Locations
  • UCLA Medical Center Los Angeles, California, United States
  • University of Florida Gainesville, Florida, United States
  • University of Miami Miami, Florida, United States
  • Cleveland Clinic Cleveland, Ohio, United States
View Trial Details
Completed

MRX-800: A Long-Term Safety Study of Maralixibat in the Treatment of Cholestatic Liver Disease in Subjects Who Previously Participated in a Maralixibat Study

NCT04168385

Conditions
Bile Duct Diseases, Biliary Tract Diseases, Cholestatic Liver Disease, +2 more
Locations
  • Children'S Hospital Los Angeles Los Angeles, California, United States
  • Riley Hospital For Children Indianapolis, Indiana, United States
  • Children's Hospital of Philadelphia Philadelphia, Pennsylvania, United States
  • Children Hospital of Pittsburgh Pittsburgh, Pennsylvania, United States
View all 17 locations
View Trial Details

Related conditions